Sugi Predict

Sugi Predict / Compounds / SCHEMBL29426671

SCHEMBL29426671

SCHEMBL29426671

CSCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CRHR1 P34998 1/20 0.59
▸ CRHR2 Q13324 1/20 0.59
▸ GLP1R P43220 8/20 0.53
▸ OPRL1 P41146 4/20 0.51
▸ CALCR P30988 3/20 0.51
▸ BACE1 P56817 1/20 0.50
▸ HCRTR1 O43613 1/20 0.48
▸ HCRTR2 O43614 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7454936 0.91 GLP1R (0.55) CRHR1CRHR2GLP1RCALCR
SCHEMBL7454951 0.91 GLP1R (0.55) CRHR1CRHR2GLP1RCALCR
SCHEMBL30963661 0.90 CRHR1 (0.62) CRHR1CRHR2GLP1ROPRL1CALCR
SCHEMBL30787422 0.88 CRHR1 (0.69) CRHR1CRHR2GLP1RCALCRBACE1
SCHEMBL29461369 0.87 BACE1 (0.54) CRHR1CRHR2GLP1RCALCRBACE1
SCHEMBL30804653 0.85 CALCR (0.59) CRHR1CRHR2GLP1RCALCR
SCHEMBL7447502 0.85 GLP1R (0.53) GLP1R
SCHEMBL7447496 0.85 GLP1R (0.53) GLP1R
SCHEMBL31098050 0.84 CALCR (0.65) CRHR1CRHR2GLP1RCALCR
SCHEMBL29994110 0.83 CALCR (0.58) CRHR1CRHR2GLP1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113444183-B Fusion partners for peptide production 佩利肯科技控股公司 2025-06-17 — — CN disclosed
CN-112088168-B Chemoselective sulfhydryl coupling with alkene-or alkyne-thiophosphonates and-phosphonates 柏林合作研究学会 2025-02-14 — — CN disclosed
EP-4504970-A1 COMPOSITIONS AND ANALYSIS OF DEPHOSPHORYLATED OLIGORIBONUCLEOTIDES New England Biolabs, Inc. (US) 2025-02-12 — — EP disclosed
CN-112840027-B Enzymatic compositions for carbohydrate antigen cleavage, methods, uses, devices and systems related thereto 不列颠哥伦比亚大学 2025-01-10 — — CN disclosed
US-12173368-B2 Compositions and analysis of dephosphorylated oligoribonucleotides NEW ENGLAND BIOLABS, INC. (US) 2024-12-24 — — US disclosed
CN-112512581-B Antibody constructs against CLDN18.2 and CD3 安进研发（慕尼黑）股份有限公司 2024-12-17 — — CN disclosed
US-20240301485-A1 Compositions and Analysis of Dephosphorylated Oligoribonucleotides NEW ENGLAND BIOLABS, INC. (US) 2024-09-12 — — US disclosed
CN-110330563-B Modified serine protease inhibitors for the treatment of hemorrhagic diseases 剑桥实业有限公司 2024-03-29 — — CN disclosed
CN-117545511-A Thiol coupling with unsaturated phosphorus (V) compounds 柏林合作研究学会 2024-02-09 — — CN disclosed
CN-108473987-B Binding members with altered diverse scaffold domains 马可讯治疗有限公司 2024-01-02 — — CN disclosed
US-20230287489-A1 Compositions and Analysis of Dephosphorylated Oligoribonucleotides NEW ENGLAND BIOLABS, INC. (US) 2023-09-14 — — US disclosed
CN-114349848-B SAA recombinant protein and preparation method and application thereof 南京岚煜生物科技有限公司 2023-09-12 — — CN disclosed
CN-109071635-B Contorsbody-single stranded target conjugates 豪夫迈·罗氏有限公司 2023-09-01 — — CN disclosed
CN-116391047-A Mass spectrometry-based methods and kits for nucleic acid detection and disease diagnosis YYZ医药科技有限公司 2023-07-04 — — CN disclosed
CN-112839512-B Enzymatic compositions for carbohydrate antigen cleavage on donor organs, methods and uses related thereto 不列颠哥伦比亚大学 2023-06-13 — — CN disclosed
CN-116134151-A Multiplex analyte detection 维塔生物科技公司 2023-05-16 — — CN disclosed
CN-110256567-B Method for selecting and generating a customized targeting entity comprising at least two different binding entities and use thereof 弗·哈夫曼-拉罗切有限公司 2023-04-25 — — CN disclosed
CN-115605587-A Novel recombinant lysins and their use in the treatment of gram-negative bacterial infections 特卢姆治疗有限公司（ES） 2023-01-13 — — CN disclosed
CN-114349848-A SAA recombinant protein and preparation method and application thereof 南京岚煜生物科技有限公司 2022-04-15 — — CN disclosed
CN-114126636-A Compositions for treating insulin deficiency disorders 日内瓦大学 2022-03-01 — — CN disclosed
Send feedback